Aneurysm Syndromes Caused by Mutations in the TGF- Receptor
Bart L. Loeys, M.D., Ph.D., Ulrike Schwarze, M.D., Tammy Holm, M.D., Bert L. Callewaert, M.D., George H. Thomas, Ph.D., Hariyadarshi Pannu, Ph.D., Julie F. De Backer, M.D., Gretchen L. Oswald, M.S., Sofie Symoens, B.S., Sylvie Manouvrier, M.D., Ph.D., Amy E. Roberts, M.D., Francesca Faravelli, M.D., M. Alba Greco, M.D., Reed E. Pyeritz, M.D., Ph.D., Dianna M. Milewicz, M.D., Ph.D., Paul J. Coucke, Ph.D., Duke E. Cameron, M.D., Alan C. Braverman, M.D., Peter H. Byers, M.D., Anne M. De Paepe, M.D., Ph.D., and Harry C. Dietz, M.D.
Background The Loeys–Dietz syndrome is a recently describedautosomal dominant aortic-aneurysm syndrome with widespreadsystemic involvement. The disease is characterized by the triadof arterial tortuosity and aneurysms, hypertelorism, and bifiduvula or cleft palate and is caused by heterozygous mutationsin the genes encoding transforming growth factor receptors1 and 2 (TGFBR1 and TGFBR2, respectively).
Methods We undertook the clinical and molecular characterizationof 52 affected families. Forty probands presented with typicalmanifestations of the Loeys–Dietz syndrome. In view ofthe phenotypic overlap between this syndrome and vascular Ehlers–Danlossyndrome, we screened an additional cohort of 40 patients whohad vascular Ehlers–Danlos syndrome without the characteristictype III collagen abnormalities or the craniofacial featuresof the Loeys–Dietz syndrome.
Results We found a mutation in TGFBR1 or TGFBR2 in all probandswith typical Loeys–Dietz syndrome (type I) and in 12 probandspresenting with vascular Ehlers–Danlos syndrome (Loeys–Dietzsyndrome type II). The natural history of both types was characterizedby aggressive arterial aneurysms (mean age at death, 26.0 years)and a high incidence of pregnancy-related complications (in6 of 12 women). Patients with Loeys–Dietz syndrome typeI, as compared with those with type II, underwent cardiovascularsurgery earlier (mean age, 16.9 years vs. 26.9 years) and diedearlier (22.6 years vs. 31.8 years). There were 59 vascularsurgeries in the cohort, with one death during the procedure.This low rate of intraoperative mortality distinguishes theLoeys–Dietz syndrome from vascular Ehlers–Danlossyndrome.
Conclusions Mutations in either TGFBR1 or TGFBR2 predisposepatients to aggressive and widespread vascular disease. Theseverity of the clinical presentation is predictive of the outcome.Genotyping of patients presenting with symptoms like those ofvascular Ehlers–Danlos syndrome may be used to guide therapy,including the use and timing of prophylactic vascular surgery.
Source Information
From the McKusick–Nathans Institute for Genetic Medicine (B.L.L., T.H., G.H.T., G.L.O., H.C.D.) and the Department of Surgery (D.E.C.), Johns Hopkins University School of Medicine, and the Kennedy Krieger Institute (G.H.T.) — both in Baltimore; the Departments of Pathology and Medicine, University of Washington, Seattle (U.S., P.H.B.); the Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium (B.L.L., B.L.C., J.F.D.B., S.S., P.J.C., A.M.D.P.); the Department of Medicine, University of Texas, Houston (H.P., D.M.M.); the Department of Clinical Genetics, University Hospital, Lille, France (S.M.); the Department of Clinical Genetics, Harvard Medical School, Boston (A.E.R.); the Department of Human Genetics, Ospedale Galliera, Genoa, Italy (F.F.); the Department of Pathology, New York University School of Medicine, New York (M.A.G.); the Department of Medicine, University of Pennsylvania, Philadelphia (R.E.P.); the Department of Medicine, Washington University School of Medicine, St. Louis (A.C.B.); and Howard Hughes Medical Institute, Chevy Chase, Md. (H.C.D.).
Address reprint requests to Dr. Loeys at the Center for Medical Genetics, Ghent University Hospital, Bldg. 0K5, De Pintelaan 185, 9000 Ghent, Belgium, or at bart.loeys{at}ugent.be.
Faivre, L, Collod-Beroud, G, Child, A, Callewaert, B, Loeys, B L, Binquet, C, Gautier, E, Arbustini, E, Mayer, K, Arslan-Kirchner, M, Stheneur, C, Kiotsekoglou, A, Comeglio, P, Marziliano, N, Halliday, D, Beroud, C, Bonithon-Kopp, C, Claustres, M, Plauchu, H, Robinson, P N, Ades, L, De Backer, J, Coucke, P, Francke, U, De Paepe, A, Boileau, C, Jondeau, G
(2008). Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J. Med. Genet.
45: 384-390
[Abstract][Full Text]
Lopez, L., Arheart, K. L., Colan, S. D., Stein, N. S., Lopez-Mitnik, G., Lin, A. E., Reller, M. D., Ventura, R., Silberbach, M.
(2008). Turner Syndrome Is an Independent Risk Factor for Aortic Dilation in the Young. Pediatrics
121: e1622-e1627
[Abstract][Full Text]
Keane, M. G., Pyeritz, R. E.
(2008). Medical Management of Marfan Syndrome. Circulation
117: 2802-2813
[Full Text]
Melenovsky, V., Adamira, M., Kautznerova, D., Voska, L., Weichet, J., Loeys, B., Pirk, J.
(2008). Aortic dissection in a young man with Loeys-Dietz syndrome.. J. Thorac. Cardiovasc. Surg.
135: 1174-1175.e1
[Full Text]
Zaiman, A. L., Podowski, M., Medicherla, S., Gordy, K., Xu, F., Zhen, L., Shimoda, L. A., Neptune, E., Higgins, L., Murphy, A., Chakravarty, S., Protter, A., Sehgal, P. B., Champion, H. C., Tuder, R. M.
(2008). Role of the TGF-{beta}/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension. Am. J. Respir. Crit. Care Med.
177: 896-905
[Abstract][Full Text]
Newman, J. H., Phillips, J. A. III, Loyd, J. E.
(2008). Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies. ANN INTERN MED
148: 278-283
[Abstract][Full Text]
Sareli, A. E., Janssen, W. J., Sterman, D., Saint, S., Pyeritz, R. E.
(2008). What's the Connection? -- A 26-year-old white man presented to our referral hospital with a 1-month history of persistent cough productive of white sputum, which was occasionally tinged with blood. NEJM
358: 626-632
[Full Text]
Cheli, Y., Jensen, D., Marchese, P., Habart, D., Wiltshire, T., Cooke, M., Fernandez, J. A., Ware, J., Ruggeri, Z. M., Kunicki, T. J.
(2008). The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood
111: 1266-1273
[Abstract][Full Text]
Kuivaniemi, H., Platsoucas, C. D., Tilson, M. D. III
(2008). Aortic Aneurysms: An Immune Disease With a Strong Genetic Component. Circulation
117: 242-252
[Full Text]
Matura, L. A., Ho, V. B., Rosing, D. R., Bondy, C. A.
(2007). Aortic Dilatation and Dissection in Turner Syndrome. Circulation
116: 1663-1670
[Abstract][Full Text]
McKellar, S. H., Tester, D. J., Yagubyan, M., Majumdar, R., Ackerman, M. J., Sundt, T. M. III
(2007). Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg.
134: 290-296
[Abstract][Full Text]
Lee, R. S., Fazel, S., Schwarze, U., Fleischmann, D., Berry, G. J., Liang, D., Miller, D. C., Mitchell, R. S.
(2007). Rapid aneurysmal degeneration of a Stanford type B aortic dissection in a patient with Loeys-Dietz syndrome. J. Thorac. Cardiovasc. Surg.
134: 242-243
[Full Text]
Johnson, P. T., Chen, J. K., Loeys, B. L., Dietz, H. C., Fishman, E. K.
(2007). Loeys-Dietz Syndrome: MDCT Angiography Findings. Am. J. Roentgenol.
189: W29-W35
[Abstract][Full Text]
Waldmuller, S., Muller, M., Warnecke, H., Rees, W., Schols, W., Walterbusch, G., Ennker, J., Scheffold, T.
(2007). Genetic testing in patients with aortic aneurysms/dissections: a novel genotype/phenotype correlation?. Eur. J. Cardiothorac. Surg.
31: 970-975
[Abstract][Full Text]
Drera, B., Barlati, S., Colombi, M., Cartwright, M. S., Roach, E. S.
(2007). ISCHEMIC STROKE IN AN ADOLESCENT WITH ARTERIAL TORTUOSITY SYNDROME. Neurology
68: 1637-1637
[Full Text]
Yetman, A. T., Beroukhim, R. S., Ivy, D. D., Manchester, D.
(2007). Importance of the Clinical Recognition of Loeys-Dietz Syndrome in the Neonatal Period. Pediatrics
119: e1199-e1202
[Abstract][Full Text]
Ruiz-Ortega, M., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G., Egido, J.
(2007). TGF-{beta} signaling in vascular fibrosis. Cardiovasc Res
74: 196-206
[Abstract][Full Text]
Grainger, D. J.
(2007). TGF-{beta} and atherosclerosis in man. Cardiovasc Res
74: 213-222
[Abstract][Full Text]
Graham Stuart, A., Williams, A.
(2007). Marfan's syndrome and the heart. Arch. Dis. Child.
92: 351-356
[Abstract][Full Text]
Weiss, R. M.
(2007). Lasting Effects of Lost Vascular Elasticity. Circ. Res.
100: 604-606
[Full Text]
Liang, X., Sun, Y., Schneider, J., Ding, J.-H., Cheng, H., Ye, M., Bhattacharya, S., Rearden, A., Evans, S., Chen, J.
(2007). Pinch1 Is Required for Normal Development of Cranial and Cardiac Neural Crest-Derived Structures. Circ. Res.
100: 527-535
[Abstract][Full Text]
Hoffman, J. D., Estrella, E. A.
(2007). Newborn Presentation of Connective Tissue Disorders. NeoReviews
8: e110-e119
[Abstract][Full Text]
Williams, J. A., Loeys, B. L., Nwakanma, L. U., Dietz, H. C., Spevak, P. J., Patel, N. D., Francois, K., DeBacker, J., Gott, V. L., Vricella, L. A., Cameron, D. E.
(2007). Early Surgical Experience With Loeys-Dietz: A New Syndrome of Aggressive Thoracic Aortic Aneurysm Disease. Ann. Thorac. Surg.
83: S757-S763
[Abstract][Full Text]
Chaudhry, S. S., Cain, S. A., Morgan, A., Dallas, S. L., Shuttleworth, C. A., Kielty, C. M.
(2007). Fibrillin-1 regulates the bioavailability of TGF{beta}1. J. Cell Biol.
176: 355-367
[Abstract][Full Text]
Charitakis, K., Basson, C. T.
(2007). Degenerating Heart Valves: Fill Them up With Filamin?. Circulation
115: 2-4
[Full Text]
Malik, I.
(2006). JournalScan. Heart
92: 1886-1888
[Full Text]
Arbustini, E., Marziliano, N., Magrassi, L., Loeys, B. L., Dietz, H. C.
(2006). Aneurysm Syndromes and TGF-{beta} Receptor Mutations. NEJM
355: 2155-2156
[Full Text]
BEE, K. J, WILKES, D., DEVEREUX, R. B, LERMAN, B. B, DIETZ, H. C, BASSON, C. T
(2006). Structural and Functional Genetic Disorders of the Great Vessels and Outflow Tracts. Ann. N. Y. Acad. Sci.
1085: 256-269
[Abstract][Full Text]
Oderich, G. S.
(2006). Current Concepts in the Diagnosis and Management of Vascular Ehlers-Danlos Syndrome. PERSPECT VASC SURG ENDOVASC THER
18: 206-214
Ellison, J.
(2006). Commentary on "Current Concepts in the Diagnosis and Management of Vascular Ehlers-Danlos Syndrome". PERSPECT VASC SURG ENDOVASC THER
18: 215-216
Gelb, B. D.
(2006). Marfan's Syndrome and Related Disorders -- More Tightly Connected Than We Thought. NEJM
355: 841-844
[Full Text]
Receptor
receptors 1 and 2 (TGFBR1 and TGFBR2, respectively). 
Previous
